A comparison of two visual inspection methods for cervical cancer screening among HIV-infected women in Kenya;Comparaison de deux méthodes d'inspection visuelle pour le dépistage du cancer du col de l'utérus chez les femmes infectées par le VIH au Kenya

Bulletin of the World Health Organization

Volumn 92, Issue 3, 2014, Pages 195-203

  Huchko, Megan J ^a   Sneden, Jennifer ^a   Leslie, Hannah H ^b   Abdulrahim, Naila ^c   Maloba, May ^c   Bukusi, Elizabeth ^c   Cohen, Craig R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; LUGOL; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; IODIDE; LUGOL'S SOLUTION;

ADULT; ARTICLE; CANCER SCREENING; CLINICAL EVALUATION; CLINICAL PROTOCOL; COLPOSCOPY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GOLD STANDARD; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; KENYA; MAJOR CLINICAL STUDY; MIDDLE AGED; OUTCOME ASSESSMENT; PREDICTIVE VALUE; TUMOR BIOPSY; UTERINE CERVIX CANCER; VISUAL INSPECTION; AGE DISTRIBUTION; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; MULTICENTER STUDY; PAPANICOLAOU TEST; PATHOLOGY; PROCEDURES; STATISTICAL MODEL; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS;

ACETIC ACID; ADULT; AGE DISTRIBUTION; COLPOSCOPY; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INDICATORS AND REAGENTS; IODIDES; KENYA; LOGISTIC MODELS; MIDDLE AGED; NEOPLASM STAGING; PAPANICOLAOU TEST; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84896834968     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.13.122051     Document Type: Article

References (28)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917. doi: http://dx.doi.org/10.1002/ijc.25516 PMID:21351269
2. Sasco AJ, Jaquet A, Boidin E, Ekouevi DK, Thouillot F, Lemabec T et al. The challenge of AIDS-related malignancies in sub-Saharan Africa. PLoS One 2010;5:e8621. doi: http://dx.doi.org/10.1371/journal.pone.0008621 PMID:20066157
3. Moodley JR, Hoffman M, Carrara H, Allan BR, Cooper DD, Rosenberg L et al. HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study. BMC Cancer 2006;6:135. doi: http://dx.doi.org/10.1186/1471-2407-6-135 PMID:16719902
4. Global Report: UNAIDS Report on the Global AIDS Epidemic 2010. Geneva: UNAIDS; 2010.
5. Arbyn M, Sankaranarayanan R, Muwonge R, Keita N, Dolo A, Mbalawa CG et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer 2008;123:153-60. doi: http://dx.doi.org/10.1002/ijc.23489 PMID:18404671
6. Holschneider CH, Ghosh K, Montz FJ. See-and-treat in the management of high-grade squamous intraepithelial lesions of the cervix: a resource utilization analysis. Obstet Gynecol 1999;94:377-85. doi: http://dx.doi.org/10.1016/S0029-7844(99)00337-3 PMID:10472863
7. Dols JA, Reid G, Brown JM, Tempelman H, Bontekoe TR, Quint WG et al. HPV Type Distribution and Cervical Cytology among HIV-Positive Tanzanian and South African Women. ISRN Obstet Gynecol 2012;2012:514146. PMID:22811925
8. Silverberg MJ, Schneider MF, Silver B, Anastos KM, Burk RD, Minkoff H et al. Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. Clin Vaccine Immunol 2006;13:511-9. doi: http://dx.doi.org/10.1128/CVI.13.4.511-519.2006 PMID:16603621
9. Comprehensive cervical cancer control: a guide to essential practice. Geneva: World Health Organization; 2006.
10. Horo A, Jaquet A, Ekouevi DK, Toure B, Coffie PA, Effi B et al.; IeDEA West Africa Collaboration. Cervical cancer screening by visual inspection in Côte d'Ivoire, operational and clinical aspects according to HIV status. BMC Public Health 2012;12:237. doi: http://dx.doi.org/10.1186/1471-2458-12-237 PMID:22443255
11. Maiman M, Fruchter RG, Sedlis A, Feldman J, Chen P, Burk RD et al. Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol Oncol 1998;68:233-9. doi: http://dx.doi.org/10.1006/gyno.1998.4938 PMID:9570972
12. Moon TD, Silva-Matos C, Cordoso A, Baptista AJ, Sidat M, Vermund SH. Implementation of cervical cancer screening using visual inspection with acetic acid in rural Mozambique: successes and challenges using HIV care and treatment programme investments in Zambézia Province. J Int AIDS Soc 2012;15:17406. doi: http://dx.doi.org/10.7448/IAS.15.2.17406 PMID:22713260
13. Mabeya H, Khozaim K, Liu T, Orango O, Chumba D, Pisharodi L et al. Comparison of conventional cervical cytology versus visual inspection with acetic acid among human immunodeficiency virus-infected women in Western Kenya. J Low Genit Tract Dis 2012;16:92-7. doi: http://dx.doi.org/10.1097/LGT.0b013e3182320f0c PMID:22126834
14. Firnhaber C, Mayisela N, Mao L, Williams S, Swarts A, Faesen M et al. Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa. PLoS One 2013;8:e53494. doi: http://dx.doi.org/10.1371/journal.pone.0053494 PMID:23326441
15. Lewis Kulzer J, Penner JA, Marima R, Oyaro P, Oyanga AO, Shade SB et al. Family model of HIV care and treatment: a retrospective study in Kenya. J Int AIDS Soc 2012;15:8. doi: http://dx.doi.org/10.1186/1758-2652-15-8 PMID:22353553
16. Huchko MJ, Maloba M, Bukusi EA. Safety of the loop electrosurgical excision procedure performed by clinical officers in an HIV primary care setting. Int J Gynaecol Obstet 2010;111:89-90. doi: http://dx.doi.org/10.1016/j.ijgo.2010.05.014 PMID:20630528
17. Walker P, Dexeus S, De Palo G, Barrasso R, Campion M, Girardi F et al.; Nomenclature Committee of the International Federation for Cervical Pathology and Colposcopy. International terminology of colposcopy: an updated report from the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol 2003;101:175-7. doi: http://dx.doi.org/10.1016/S0029-7844(02)02581-4 PMID:12517664
18. Eddings W, Marchenko Y. Diagnostics for multiple imputation in Stata. Stata J 2012;12:353-67.
19. Santesso N, Schünemann H, Blumenthal P, De Vuyst H, Gage J, Garcia F et al.; World Health Organization Steering Committee for Recommendations on Use of Cryotherapy for Cervical Cancer Prevention. World Health Organization Guidelines: Use of cryotherapy for cervical intraepithelial neoplasia. Int J Gynaecol Obstet 2012;118:97-102. doi: http://dx.doi.org/10.1016/j.ijgo.2012.01.029 PMID:22727415
20. Leinonen MK, Nieminen P, Lönnberg S, Malila N, Hakama M, Pokhrel A et al. Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland. BMJ 2012;345(nov29 3):e7789. doi: http://dx.doi.org/10.1136/bmj.e7789 PMID:23197596
21. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A et al.; New Technologies for Cervical Cancer screening (NTCC) Working Group. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010;11:249-57. doi: http://dx.doi.org/10.1016/S1470-2045(09)70360-2 PMID:20089449
22. Cremer M, Conlisk E, Maza M, Bullard K, Peralta E, Siedhoff M et al. Adequacy of visual inspection with acetic acid in women of advancing age. Int J Gynaecol Obstet 2011;113:68-71. doi: http://dx.doi.org/10.1016/j.ijgo.2010.10.018 PMID:21272884
23. De Vuyst H, Mugo NR, Chung MH, McKenzie KP, Nyongesa-Malava E, Tenet V et al. Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya. Br J Cancer 2012;107:1624-30. doi: http://dx.doi.org/10.1038/bjc.2012.441 PMID:23033006
24. Longatto-Filho A, Hammes LS, Sarian LO, Roteli-Martins C, Derchain SF, Eržen M et al. Hormonal contraceptives and the length of their use are not independent risk factors for high-risk HPV infections or high-grade CIN. Gynecol Obstet Invest 2011;71:93-103. doi: http://dx.doi.org/10.1159/000320742 PMID:21150159
25. Syrjänen K. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors. Eur J Gynaecol Oncol 2008;29:205-21. PMID:18592782
26. Denny LA, Franceschi S, de Sanjosé S, Heard I, Moscicki AB, Palefsky J. Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine 2012;30(Suppl 5):F168-74. doi: http://dx.doi.org/10.1016/j.vaccine.2012.06.045 PMID:23199960
27. Huchko MJ, Bukusi EA, Cohen CR. Building capacity for cervical cancer screening in outpatient HIV clinics in the Nyanza province of western Kenya. Int J Gynaecol Obstet 2011;114:106-10. doi: http://dx.doi.org/10.1016/j.ijgo.2011.02.009 PMID:21620403
28. Woo VG, Cohen CR, Bukusi EA, Huchko MJ. Loop electrosurgical excision procedure: safety and tolerability among human immunodeficiency virus-positive Kenyan women. Obstet Gynecol 2011;118:554-9. doi: http://dx.doi.org/10.1097/AOG.0b013e31822b0991 PMID:21860283